# Celularity Inc.: Form D filings

Celularity Inc., a biotechnology company in Warren, NJ, filed 2 Form D notices with the SEC between 2017 and 2018. The latest, on November 13, 2018, reports $77.7 million sold of a $202.7 million offering to 5 investors.

Find out what Celularity Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Celularity%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Celularity%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcelularity-inc-1716918)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Celularity%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Celularity%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcelularity-inc-1716918)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 33 Technology DRIVE, Warren, NJ, 07059
- Phone: (908) 673-9000
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2016
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1716918

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 13, 2018 | New notice | $202,699,988 | $77,699,988 | $125,000,000 | 5 | May 7, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1716918/000171691818000001/0001716918-18-000001-index.htm) |
| Sep 28, 2017 | New notice | $40,000,004 | $40,000,004 | $0 | 16 | Aug 15, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1716918/000171691817000001/0001716918-17-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Joseph Kaminski | Executive Officer |  |
| Carlos Ramirez | Executive Officer |  |
| Gertjan Bartlema | Executive Officer |  |
| John Sculley | Director |  |
| Beth Steinbrenner | Executive Officer |  |
| David Lemus | Director |  |
| Henry Ji | Director |  |
| Tim Smith | Executive Officer |  |
| Andrew Pecora | Director |  |
| Jaisim Shah | Director |  |
| Xiaokui Zhang | Executive Officer |  |
| Nassir Habboubi | Executive Officer |  |
| Andrew von Eschenbach | Director |  |
| Jodi Gurney | Executive Officer |  |
| Curtis Quigley | Executive Officer |  |
| Bill Waller | Executive Officer |  |
| Peter Diamandis | Director |  |
| Kok Thay Lim | Director |  |
| John Haines | Executive Officer |  |
| Robert Hariri | Executive Officer, Director |  |
| Bill Maris | Director |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Nov 12, 2018](https://specstream.ai/data/form-d/week/2018-11-12) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Celularity Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).